MBX
MBX Biosciences·NASDAQ
--
--(--)
--
--(--)
MBX fundamentals
MBX Biosciences (MBX) released its earnings on Mar 17, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.47 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.47
--
Report date
Mar 17, 2025
EPS
Actual | -0.47 |
Forecast | -0.5731 |
Surprise | +17.99% |
Revenue
Actual | 0 |
Forecast | 0 |
Surprise | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in MBX Biosciences's revenue and profit?What is the market's earnings forecast for MBX Biosciences next quarter?What were the key takeaways from MBX Biosciences's earnings call?Did MBX Biosciences beat or miss consensus estimates last quarter?What does MBX Biosciences do and what are its main business segments?What is MBX Biosciences's latest dividend and current dividend yield?What guidance did MBX Biosciences's management provide for the next earnings period?What is the revenue and EPS growth rate for MBX Biosciences year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
